Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SSY GroupLJUIF 86 PB Ratio is 1.25 as of Jul. 27, 2026, which is 49% below its 10-year median of 2.47. GuruFocus rates LJUIF with a GF Score™ of 86/100 and a GF Value™ of $0.51. The stock has 8 warning signs investors should review. Among 924 Drug Manufacturers companies, SSY Group ranks better than 77.38% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-27), SSY Group's share price is $0.40255. SSY Group's Book Value per Share for the quarter that ended in Dec. 2025 was $0.32. Hence, SSY Group's PB Ratio of today is 1.25.
The historical rank and industry rank for SSY Group's PB Ratio or its related term are showing as below:
LJUIF'
s PB Ratio Range Over the Past 10 Years
Min: 0.84 Med: 2.47 Max: 7.7
Current: 0.96
During the past 13 years, SSY Group's highest PB Ratio was 7.70. The lowest was 0.84. And the median was 2.47.
LJUIF's PB Ratio is ranked better than 77.38% of 924
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs LJUIF: 0.96
During the past 12 months, SSY Group's average Book Value Per Share Growth Rate was 2.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of SSY Group was 52.10% per year. The lowest was -1.30% per year. And the median was 11.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
SSY Group PB Ratio Related Terms
SSY Group PB Ratio Historical Data
* Premium members only.
The historical data trend for SSY Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where SSY Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
SSY Group's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
SSY Group (LJUIF) has a PB Ratio of 1.25 as of Jul. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SSY Group and its competitors. This is 49% below median its historical median of 2.47. Over the past decade, SSY Group's PB Ratio has ranged from 0.84 to 7.70. According to the industry distribution chart, SSY Group ranks #209 out of 924 companies in the Drug Manufacturers industry, placing it in the top 22.6%.
Is SSY Group's PB Ratio too high?
SSY Group's current PB Ratio of 1.25 is 49% below median its 10-year median of 2.47. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 7.70. The Drug Manufacturers industry median PB Ratio is 1.90. SSY Group's value of 1.25 is 34.2% below this industry median. Based on the distribution chart, SSY Group ranks #209 out of 924 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, SSY Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does SSY Group's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, SSY Group ranks #209 out of 924 companies for PB Ratio. This places SSY Group in the top 23% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.90. SSY Group's value of 1.25 is 34.2% below this benchmark. Historically, SSY Group's own PB Ratio has ranged from 0.84 to 7.70 over the past decade. While the company's 10-year median is 2.47 vs. the industry median of 1.90, SSY Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SSY Group's current PB Ratio of 1.25 is 34.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SSY Group and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SSY Group's current PB Ratio is 1.25, which is 49% below median its own 10-year median of 2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
SSY Group (LJUIF) has a current PB Ratio of 1.25. The stock's GF Value™ is $0.51, compared to a current price of $0.40 — trading 21.1% below its estimated fair value. The current PB Ratio is 1.25, which is 49% below median its 10-year median of 2.47 and 34.2% below the Drug Manufacturers industry median of 1.90. SSY Group's overall GF Score™ is 86/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For SSY Group (LJUIF), the current PB Ratio is 1.25 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SSY Group (LJUIF) Overvalued in 2026?
Based on GuruFocus' analysis, SSY Group stock appears to be undervalued.
The current stock price of $0.40 is trading 21.1% below its estimated GF Value™ of $0.51.
Key valuation signals for LJUIF:
PB Ratio: 1.25 (49% below median its 10-year median of 2.47)
GF Value™: $0.51 vs. price of $0.40 (21.1% below fair value)
Industry Position: 34.2% below the Drug Manufacturers median (#209 of 924)
No single metric tells the full story. See the LJUIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
86GF Score
Get the complete analysis for LJUIF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LJUIF has been successfully added to your 
